Eliquis (Apixaban) & Gastrointestinal (GI) Bleed, Intracranial Hemorrhage, and Stroke

Basic Details
Status
Complete
Last Updated
Monday, September 28, 2020
Original Posting Date
Health Outcome(s)
gastrointestinal (GI) bleed
intracranial hemorrhage
stroke
Purpose
Drug and Outcome Analysis
Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
No
Analytic Code Link(s) (1)
Stroke, Gastrointestinal Bleeding, and Intracranial Hemorrhage Following Apixaban or Warfarin Use in Patients with Non-Valvular Atrial Fibrillation: A Propensity Score Matched Analysis
Result(s) (2)
Stroke, Gastrointestinal Bleeding, and Intracranial Hemorrhage Following Apixaban or Warfarin Use in Patients with Non-Valvular Atrial Fibrillation: A Propensity Score Matched Analysis Ischemic Stroke, Intracranial Hemorrhage, and Gastrointestinal Hemorrhage Among New Users of Apixaban and Warfarin
Related Publication(s) and/or Presentation(s) (2)
Publication: Risk of Stroke and Bleeding in Atrial Fibrillation Treated with Apixaban Compared with Warfarin Presentation: Risk of Stroke and Bleeding in Nonvalvular Atrial Fibrillation Treated with Apixaban Compared to Warfarin in the Sentinel System